Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Michael S. Klein net worth and biography

Michael Klein Biography and Net Worth

CEO of iCAD

Michael S. Klein is a businessperson who has been at the helm of 5 different companies. Presently, Mr. Klein occupies the position of Executive Chairman & Chief Executive Officer at iCAD, Inc.

Mr. Klein previously was Chief Executive Officer & Director at SonaCare Medical LLC, Chief Executive Officer for Inflection Point Consulting, President-Civco Radiation Oncology Division at Roper Technologies, Inc., Vice President-Sales & Marketing of Becton, Dickinson & Co., Chairman, President & Chief Executive Officer at R2 Technology, Inc., President & Chief Executive Officer for Xoft, Inc., General Manager-Oncology Systems at Varian Medical Systems and Director-Sales & Marketing Training at SCM Corp.

He received an MBA from New York Institute of Technology, a graduate degree from Harvard University, a graduate degree from Babson College and an undergraduate degree from State University of New York at Albany.

How do I contact Michael S. Klein?: The corporate mailing address for Mr. Klein and other iCAD executives is 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062. iCAD can also be reached via phone at (603) 882-5200 and via email at [email protected]. Learn More on Michael S. Klein's contact information.
Has Michael S. Klein been buying or selling shares of iCAD?: Michael S. Klein has not been actively trading shares of iCAD during the last ninety days. Most recently, on Wednesday, December 8th, Michael S. Klein bought 13,475 shares of iCAD stock. The stock was acquired at an average cost of $7.38 per share, with a total value of $99,445.50. Learn More on Michael S. Klein's trading history.
Who are iCAD's active insiders?: iCAD's insider roster includes Charles Carter (CFO), Jonathan Go (CTO), Timothy Irish (Director), Michael Klein (CEO), Andy Sassine (Director), Stacey Stevens (President), and Susan Wood (Director). Learn More on iCAD's active insiders.

Michael S. Klein Insider Trading History at iCAD

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/8/2021	Buy	13,475	$7.38	$99,445.50

Michael S. Klein Buying and Selling Activity at iCAD

iCAD Company Overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Today's Range

Now: $1.60

$1.49

$1.60

50 Day Range

MA: $1.72

$1.39

$2.40

2 Week Range

Now: $1.60

$1.18

$2.65

Volume

138,550 shs

Average Volume

174,536 shs

Market Capitalization

$42.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

This company will win the AI race

From Porter & Company | Ad